Loading...

FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitations

Internal tandem duplications of the FMS-like tyrosine kinase 3 (FLT3) gene are one of the most frequent gene mutations in acute myeloid leukemia (AML) and are associated with poor clinical outcome. The remission rate is high with intensive chemotherapy, but most patients eventually relapse. During t...

Full description

Saved in:
Bibliographic Details
Published in:Leuk Lymphoma
Main Authors: Kayser, Sabine, Levis, Mark J.
Format: Artigo
Language:Inglês
Published: 2013
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4333682/
https://ncbi.nlm.nih.gov/pubmed/23631653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2013.800198
Tags: Add Tag
No Tags, Be the first to tag this record!